ASX AnnouncementPercheron Therapeutics LimitedABN 41 095 060 745ASX: PER | FSE: AWY | US OTC: ATHJY CHAIR’S ADDRESS TO THE AGM Melbourne, Australia – 7 October 2026: In advance of this morning’s Annual General Meeting of shareholders to be held at 10:00am, and in accordance with...
Annual General Meeting - Chair Address
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
In the deck
Earlier from Percheron Therapeutics
- Proposed issue of securities - PER
- Final Director's Interest Notice
- Initial Director's Interest Notice
- Dr Michael Baker Commences as CEO and MD
- Notice under S708A
Later from Percheron Therapeutics
- Annual General Meeting - Management Presentation
- Results of Annual General Meeting
- Notification regarding unquoted securities - PER
- Change of Director's Interest Notice
- Application for quotation of securities - PER
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics